Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery
Condition: Epithelioid Hemangioendothelioma Interventions: Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration; Drug: Trametinib Sponsor: National Cancer Institute (NCI) Recruiting - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Hemangioendothelioma